WISE closed an oversubscribed €30M Series D. The Italian company builds soft, flexible implantable electrodes designed to sit against tissue more closely than the rigid versions used in most neuromonitoring, neuromodulation, and BCI devices. The funding takes its lead implant, Heron, toward certification and a first-in-human study, alongside scale-up of its wider electrode range.